CPEs - Resistance Mechanisms Flashcards

1
Q

Talk about Carbapenems

NB: theres a good piece on the clinical significance at the end of the lecture

A

B-lactams with broad spectrum of activity against Gram negative pathogens

Last effective defence against MDR strains e.g. E. Coli or K. pneumoniae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Talk about carbapenemases

A

There are over 2000 classes

Class A: KPC
Class B: metallo B-lactamsases (VIM, NDM, IMP)
Class D: OXA-48 and OXA-181

Genes can be plasmid-located and associated with transposons and integrons - ability to spread

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List the big 5

A

KPC
OXA-48
IMP
VIM
NDM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Give some examples of Class A and what do they mediate resistance against

A

KPC

Resistance against penicillins, cephalosporins, carbapenems and aztreonam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What inhibits class A such as KPC

A

Boronic acid and avibactam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Give some examples of Class B and what do they mediate resistance against

A

VIM
NDM
IMP

Resistant agains all B lactams but aztreonam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What inhibits class B such as IMP, NDM and VIM?

A

EDTA and dipicolonic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Give some examples of Class C and what do they mediate resistance against

A

CMY -> not noe of big five

Penicillins, cephalosporins and aztreonam -> not reistant to carbapenems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What inhibits class C such as CMY

A

Cloxacillin
Borionic acid
Avibactam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Give some examples of Class D and what do they mediate resistance against

A

All the OXAs, 48, 23, 51, 24, 58 etc

Resistance to penicillins, cephalosporins, carbapenems and aztreonam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What inhibits class D such as OXA-48

A

Avibactam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What does KPC stand for?

A

K. pneumoniae carbapenemase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is KPC, talk about it

A

Most common carbapenemase worldwide
Transposon encoded
Class A
Endemic - worldwide spread
Has spread to Enterobacterales, P. aeruginosa and acinetobacter spp
High mortality 50% or more due to MDR
Mediates resistance to carbapenems, penicillin, cephalosporins and aztreonam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is KPC found in?

A

Initially found in K. pneumoniae

Has spread to Enterobacterales, P. aeruginosa and acinetobacter spp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Comment on spread of KPC

A

First reported in USA in 1996 but now worldwide spread

First isolate in Greece in 2007 now spread to most acute-care facilities within 2 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What clone of KPC is responsible for worldwide spread?

A

ST-258

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are KPCs resistant to?

A

Mediates resistance to carbapenems, penicillin, cephalosporins and aztreonam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Mortality of KPC

A

50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

List the Class B: Metallo-B-lactamases were concerned with

A

VIM/IMP

NDM-1 -> New Dehli metallo-B-lactamase 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Talk about VIM/IMP

A

Class B
51 variants
Integron encoded
Reported worldwide
Spread to Enterobacterales, Pseudomonas and Acinetobacter sp
Death rates between 18 and 67%
High level of production can produce resistance to all carbapenems, penicillins and all cephalosporins
NB: SUSCEPTIBLE TO AZTREONAM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What organisms are VIM/IMP found in?

A

Spread to Enterobacterales, Pseudomonas and Acinetobacter sp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Talk about the spread of VIM/IMP

A

Discovered in Japan in 1990s now reported worldwide

Higher prevalence in southern Europe and Asia

Spread to many Enterobacterales, Pseudomonas and Acinetobacter species

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the mortality associated with VIM/IMP

A

Pseudomonas and Acinetobacter sp
Death rates between 18 and 67%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is VIM/IMP resistant against?

A

High level of production can produce resistance to all carbapenems, penicillins and all cephalosporins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the telltale sign of a VIM/IMP

A

NB: SUSCEPTIBLE TO AZTREONAM

-> indicator on vitek

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Talk about NDM

A

New Dehli metallo-B-lactamase 1
Class B
16 variants
Plasmid-mediated
Originated in New delhi in 2008 but now in 40 countries
Mostly in E. Coli and K. pneumoniae
Major public health concern as it can spread in envirnoment, getting into water etc -> often multiple clones associated in spread
Resistant to carbapenems, penicillins, cephalosporins
Susceptible to aztreonam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

How is NDM spread

A

Plasmid mediated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Talk about spread of NDM

A

Originally in New Dehli in 2008
Now in 40 countries
Hotspots in India and Pakistan
Common in UK
Outbreak in 2019 in Tuscany of 227 cases

Mostly in E. coli and K. pneumoniae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What is NDM found in

A

E. Coli
K. pneumoniae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What is NDM resistant to

A

Resistant to carbapenems, penicillins, cephalosporins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What is the telltale sign of NDM

A

Susceptible to aztreonam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Talk about OXA-48 type

A

Class D
Many variants e.g. OXA-181 etc
Plasmid and transposon encoded
Originated in Turkey but rapidly spread across Europe
Fastest growing GP in Europe - now endemic in Malta and Turkey
Mortality unknown
Associated with E. Coli and K. pneumoniae
Mediates resistance to carbapenems and first generation cephalosporins
Little activity against broad spectrum cephalosporins or aztreonam
But very difficult to detect so true prevalence understimated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

How is OXA spread

A

Plasmid and transposons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

How has OXA spread

A

Oringially from turkey
reports alarmingly increasing in europe
Fastest growing CP in Europe
Endemic in malta and turkey

Associated with E. coli and K. pneumo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Mortality for OXA

A

Unkown

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Associated organisms with OXA

A

E. coli and K, pneumo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Resistance mediated by OXA

A

Mediates resistance to carbapenems and first generation cephalosporins

Little activity against broad spectrum cephalosporins or aztreonam

38
Q

Telltale sign of OXA

A

Little activity against broad spectrum cephalosporins or aztreonam

39
Q

Talk about transmission of carpanemases

A

CP enzyme carried on mobile genetic elements such as plasmids or transpons

HGT -> sharing of plasmid amongst gut flora
NB in infection control

Confers resistance to multiple organims, limiting treatment

40
Q

How might you identify an OXA-48

A

May be fully susceptible to cephalosporins unless an ESBL or AMPC also present

41
Q

How would you identify an metallo-B-lactamase producer such as VIM/IMP or NDM

A

Susceptible to aztreonam unless ESBL or AMPC also present

42
Q

What are the resistance profiles of CPEs

A

They all hydrolyse penicillins, most cephalosponrsins and some carbapenems and aztreonam - depends on group

OXA-48 CPs may be fully susceptible to cephalosporins unless also an ESBL or AmpC

MBLs are suscpetible to aztreonam unless ESBL or AMPC

However resistance phenotype can vary depending on the level of expression and association with other resistance methods e.g. effllux or permeability - MDR etc

43
Q

What are the problems with identifying carbapenemase producers

A

Not all CP producers are resistant to carbapanems

ESBLs/AmpC + porin loss can appear like a CP producer but isnt actually (CPOs vs CREs)

44
Q

Other methods of Carbapenemase resistance other than carbapenemases

A

Intrinsic resistance to CPs

Intrinsic Carbapenemases

Loss of porin and/or efflux

ESBL or AmpC + impermeability

45
Q

Where is intrinsic resistance seen

A

Non-fermenters resistant to ertapenem only

Serratia species and proteeae -> poor susceptibility to imipenem

46
Q

Intrinsic carbapenemase

A

Stenotrophomonas maltophilia
Aeromonas spp
Acinetobacter baumannii

47
Q

Loss of porin and/or efflux

A

P.aeruginosa

48
Q

ESBL or AMP C + impermeability

A

Mostly Enterobacter and Klebseilla

Rarely in E. coli

49
Q

Talk about trends in Carbapenem resistance in Europe

A

Resistance increased by more than 50% compared to 2019
ST23-K1 K. pneumoniae rapidly increasing - these are hyper virulent and invasive

50
Q

Talk about trends in Carbapenem resistance in ireland

A

1.5% increase since 2019
Lots of different outbreakd - associated with travel
small outbreaks e.g. oxa-48 in tallagh hsopital k. pneumo

51
Q

List the different outbreaks of CPOs in ireland - from beginning to 2022

A

2022: 26 outbreaks of CPE in healtchare - all OXA-48

2016-2017 largest outbreak in Dublin (OXA-48 >180 cases in 1 year)

2016 small outbreaks of VIM in mayo and NDM in waterford

2012-2016 -> regional spread, rise in CPE cases in general

2011: OXA-48 K. pneumoniae in Dublin - 12 patients

2011: first outbreak (KPC) in two hospitals, 9 patients in the midwest

2009: first sporadic CPE cases in Ireland - most linked to travel - KPC, VIM, NDM

52
Q

Results from surveillance

A

861 confirmed CPEs in 2022 found through surveillance
88% were colonisation
10% were noninvasive infection
2% were invasive

OXA-48 most common at 73% of all CPEs in Ireland

53
Q

Most common CPE in Ireland?

A

OXA-48

73% in 2022

54
Q

How are CPEs changing in Ireland over the years (2018-2022)

A

OXA-48 increasing by 12%
KPC decreasing by 25%
NDM increasing by 185%
VIM increasing by 200%

55
Q

Public Health Emergency statement

A

Minister Harris addressed CPE in 2017

56
Q

Importance of detection

A

Need a catch all method - diversity of enzymes, variation, expression etc, no ideal indicator

Have to screen, confirm and characterise CRE producers

Distinguish from AmpC b -lactamases

57
Q

Who are we screening

A

ICU
Haematology/oncology/transplant
renal dialysis
transfers
previoius cpe or contact with cpe

58
Q

How do we identify KPC in the lab

A

Meropenem resistant
Synergy with boronic acid only

= KPC or other class A CPO

59
Q

How do we identify an AmpC CPE

A

Meropenem resistant
Synergy with boronic acid and cloxacillin (a derivative of oxacillin - a penicillin)

= AmpC + porin loss

60
Q

How do we identify an MBL

A

Meropenem resistant
Synergy with dipicolinic acid only

= Metallo-B-lactamase (MBL) e.g. VIM/IMP or NDM

61
Q

How do we identify an OXA-48

A

Meropenem resistant
No synergy with any of the acids
NB: Temocillin resistant

62
Q

Telltale lab ID of OXA-48

A

Temocillin resistant

63
Q

How do we ID a ESBL with porin loss

A

Meropenem resistant
No synergy
Temocillin susceptible

=ESBL plus porin loss

64
Q

What would Mero R but synergy with boronic acid indicate?

A

KPC or another class A CPO

65
Q

What would mero R but synergy with boronic acid and cloxacillin indicate

A

AmpC plus porin loss

66
Q

What would mero R but synergy with dipicolinic acid indicate?

A

MBL such as VIM/IMP or NDM

67
Q

What would Temocillin resistant indicate

A

OXA-48

68
Q

What would Mero resistance but no synergy and temocillin susceptible indicate?

A

ESBL with porin loss

69
Q

How do we select the right carbapenem to use fot testing

A

use of eucast defined screening cut offs

Meropenem and ertapanem are used
- poor sensitivity with imipenem so its not used

70
Q

Method used

A

need a method that will catch all

71
Q

List the different methods of detecting CPEs

A

Chromagar and rectal swabs
Combination disk test (Rosco/MAST)
Double disc synergy test
Gradient strip tests e.g. imipenem + imipenem + EDTA
Combination disc tests
Clorimetric tests to detect hydrolysis
MALDI-TOF to detect hydrolysis
Immunochromatographic test to detect carbapenemase antigens
Check Direct CPE
Gene Xpert Carba-R
LightMix modular Kits

72
Q

Talk about the different agars for CPEs

A

Used to screen only as sens poor especially for OXA-48
Brilliance CRE 82% sens
ChromID/Super CARBA >95% sens
-> oxa-48 sens only 30% for both
Split agar combining CARBA with OXA-48 selective agar increases sens to 61% for OXA

73
Q

Talk about the combination disk tests

A

Also known as ROSCO or MAST disks
Comparing meropenem to selective inhibitors to distinguish between carbapenemase ty[es
Confirms CPE if zone size is greated with inhibitor

74
Q

List the Rosco disks

A

Meropenem + boronic acid = KPC
Meropenem + cloxacillin = AmpC
Meropenem + dipicolonic acid = IMP, NDM, VIM
Temocillin = R = Oxa48

75
Q

What will the Rosco discs be labelled as

A

MRP10 = meropenem
MRPBO = mero + boronic acid
MRPDP = mero + dipicolonic acid
MRPCX = mero + cloxacillin
TEMOC = temocillin 30ug

76
Q

Talk about the gradient strips for CPEs

A

Imipenem on one end
Imipenem plus EDTA on other end

Any synergy = positive

77
Q

For the inhibitor combination disc test what is used

A

Carbapenem only
Carbapenem + MBL inhibitor
Carbapenem + KPC inhibitor
Carbapenem + AMPC inhibitor

78
Q

What are the pros of inhibitor based tests for CPEs

A

Cheap
easy to perform
Most extensively evaluated - recommended by eucast for labs without special expertise in B-lactamase detection

79
Q

What are the cons of inhibitor based tests

A

Some MBL inhibitors such as EDTA act non-sepcifically -> will inhibit other CPEs
Can lack sens if enzyme expressed at low levels
Difficult to interpret if multiple resistance mechanisms are present
We have no inhibitor for OXA-48
Overnight incubation required

80
Q

List some of the colorimetric tests for CPEs

A

CarbaNP and Blue-Carba test
B CARBA test

81
Q

What are the pros and cons of colorimetric tests for CPEs

A

Results in less than 2 hours
Good sens and spec
Subjective interpretation based on colour
False negatives with mucoud strains and some enzymes -> K. pneumo
Not all primary culture medium works with test

82
Q

Talk about MALDI to detect CPEs, pros and cons

A

Detects hydrolysis
Uses Bruker MBT STAR Carba IVD kit and software
Pick colonies and resuspend in antibiotic solution then inc for 3 hours
Can be done on isolates and blood/urine
Not for in house as will have to change MALDI settings
Issues with detecting some enzymes

83
Q

Talk about immunochromatographic tests for CPEs

A

Detect carbapenemase antigens
RESIST-4: KPC, OXA48, NDM, VIM
CARBA 5: KPC, OXA-48, NDM, VIM, IMP
Excellent sens and spec from colonies and spiked blood cultures
Results in 15 mins
some issues with false negatives

84
Q

Talk about check direct for CPEs

A

Identifies CPE carriers directly from rectal swabs or cultures in 2 hours
Detects clinically prevalent carbapenemases (IMP excluded)
More sensitive then culture

85
Q

Talk about GeneXpert Cepheid Carba-R for CPE

A

Rectal swabs
All 5 CPEs
High sens, spec, ppv, npc all over 95%
accurate and rapid with less than 5 mins hands on time
55 euros per test

86
Q

Talk about the LightMix for CPEs

A

Uses LightCycler
Direct detection of colonised patients
Used in mater
Rectal swabs or blood cultures
99% sens, 100% spec
TAT about 2 hours
Only ran in batches though
Very cheap only 14 euros per test

87
Q

Clinical implications for CPEs

A

Public health threat

Community

Random outbreaks

High mortality

Carriage linked to infection

Rapid dissemination through mobile genetic determinants

prevention reliant on early active surveillance

Can be difficult to distinguish - special screening methods needed

88
Q

Talk about the general mortality with CPEs

A

x3-x6 times higher with CRE infection

mortality between 30 and 75%

65% of CRE BSIs

Delays in treatment or treatment unavailable

89
Q

Talk about CPE carriage and infection link

A

17% carriage overall but 90% linked to infection

90
Q
A